Intravenous (IV) Equipment Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis
Intravenous therapy refers to the use of infusions to deliver desired liquid medications to the veins. In common terms, intravenous infusions are known as drips and are extensively used across hospitals and healthcare centers. The need to administer timely medications to patients suffering from severe diseases has been driving demand within the global market for IV devices. Although drips are an easy way of administering the desired liquids into the body, several new IV devices have also come to the fore in recent times. Moreover, correction of electrolyte imbalances and fluid replacement therapies are also carried out with the help of IV therapy.
MARKET DYNAMICS
The intravenous (IV) equipment market has been increasing on account of the rising incidence of chronic diseases that necessitate intravenous therapy. Moreover, technology advancement in intravenous (IV) equipment market is also expected to augment its demand in the upcoming year.
MARKET SCOPE
The "Intravenous (IV) Equipment Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of intravenous (IV) equipment market with detailed market segmentation by of product type and end user. The intravenous (IV) equipment market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in intravenous (IV) equipment market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The intravenous (IV) equipment market is segmented on the basis of product type and end user. Based on product type, the market is segmented as IV catheters, infusion pumps, securement devices, drip chambers, other IV equipment, stopcocks & check valves, administration sets and needleless connectors. On the basis of end user, the market is categorized as hospitals, clinics, home care settings and ambulatory care centers.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the intravenous (IV) equipment market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The intravenous (IV) equipment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting intravenous (IV) equipment market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the intravenous (IV) equipment market in these regions.
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the intravenous (IV) equipment market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The intravenous (IV) equipment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting intravenous (IV) equipment market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the intravenous (IV) equipment market in these regions.
MARKET PLAYERS
The report covers key developments in the intravenous (IV) equipment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from intravenous (IV) equipment market are anticipated to have lucrative growth opportunities in the future with the rising demand for intravenous (IV) equipment in the global market. Below mentioned is the list of few companies engaged in the intravenous (IV) equipment market.
The report also includes the profiles of key players in intravenous (IV) equipment market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- AngioDynamics, Inc.
- B. Braun Melsungen AG
- Baxter International Inc.
- Becton, Dickinson and Company
- C. R. Bard, Inc.
- Fresenius SE & Co. KGaA
- ICU Medical, Inc.
- Moog, Inc.
- Smiths Medical
- Terumo Corporation
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Intravenous Equipment (IV) Market - By Product Type
1.3.2 Intravenous Equipment (IV) Market - By End User
1.3.3 Intravenous Equipment (IV) Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. INTRAVENOUS EQUIPMENT (IV) MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. INTRAVENOUS EQUIPMENT (IV) MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. INTRAVENOUS EQUIPMENT (IV) MARKET - GLOBAL MARKET ANALYSIS
6.1. INTRAVENOUS EQUIPMENT (IV) - GLOBAL MARKET OVERVIEW
6.2. INTRAVENOUS EQUIPMENT (IV) - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. INTRAVENOUS EQUIPMENT (IV) MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. IV CATHETERS
7.3.1. Overview
7.3.2. IV Catheters Market Forecast and Analysis
7.4. INFUSION PUMPS
7.4.1. Overview
7.4.2. Infusion Pumps Market Forecast and Analysis
7.5. SECUREMENT DEVICES
7.5.1. Overview
7.5.2. Securement Devices Market Forecast and Analysis
7.6. DRIP CHAMBERS
7.6.1. Overview
7.6.2. Drip Chambers Market Forecast and Analysis
7.7. OTHER IV EQUIPMENT
7.7.1. Overview
7.7.2. Other IV Equipment Market Forecast and Analysis
7.8. STOPCOCKS AND CHECK VALVES
7.8.1. Overview
7.8.2. Stopcocks and Check Valves Market Forecast and Analysis
7.9. ADMINISTRATION SETS
7.9.1. Overview
7.9.2. Administration Sets Market Forecast and Analysis
7.10. NEEDLELESS CONNECTORS
7.10.1. Overview
7.10.2. Needleless Connectors Market Forecast and Analysis
8. INTRAVENOUS EQUIPMENT (IV) MARKET - REVENUE AND FORECASTS TO 2028 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. CLINICS
8.4.1. Overview
8.4.2. Clinics Market Forecast and Analysis
8.5. HOME CARE SETTINGS
8.5.1. Overview
8.5.2. Home Care Settings Market Forecast and Analysis
8.6. AMBULATORY CARE CENTERS
8.6.1. Overview
8.6.2. Ambulatory Care Centers Market Forecast and Analysis
9. INTRAVENOUS EQUIPMENT (IV) MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Intravenous Equipment (IV) Market Overview
9.1.2 North America Intravenous Equipment (IV) Market Forecasts and Analysis
9.1.3 North America Intravenous Equipment (IV) Market Forecasts and Analysis - By Product Type
9.1.4 North America Intravenous Equipment (IV) Market Forecasts and Analysis - By End User
9.1.5 North America Intravenous Equipment (IV) Market Forecasts and Analysis - By Countries
9.1.5.1 United States Intravenous Equipment (IV) Market
9.1.5.1.1 United States Intravenous Equipment (IV) Market by Product Type
9.1.5.1.2 United States Intravenous Equipment (IV) Market by End User
9.1.5.2 Canada Intravenous Equipment (IV) Market
9.1.5.2.1 Canada Intravenous Equipment (IV) Market by Product Type
9.1.5.2.2 Canada Intravenous Equipment (IV) Market by End User
9.1.5.3 Mexico Intravenous Equipment (IV) Market
9.1.5.3.1 Mexico Intravenous Equipment (IV) Market by Product Type
9.1.5.3.2 Mexico Intravenous Equipment (IV) Market by End User
9.2. EUROPE
9.2.1 Europe Intravenous Equipment (IV) Market Overview
9.2.2 Europe Intravenous Equipment (IV) Market Forecasts and Analysis
9.2.3 Europe Intravenous Equipment (IV) Market Forecasts and Analysis - By Product Type
9.2.4 Europe Intravenous Equipment (IV) Market Forecasts and Analysis - By End User
9.2.5 Europe Intravenous Equipment (IV) Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Intravenous Equipment (IV) Market
9.2.5.1.1 Germany Intravenous Equipment (IV) Market by Product Type
9.2.5.1.2 Germany Intravenous Equipment (IV) Market by End User
9.2.5.2 France Intravenous Equipment (IV) Market
9.2.5.2.1 France Intravenous Equipment (IV) Market by Product Type
9.2.5.2.2 France Intravenous Equipment (IV) Market by End User
9.2.5.3 Italy Intravenous Equipment (IV) Market
9.2.5.3.1 Italy Intravenous Equipment (IV) Market by Product Type
9.2.5.3.2 Italy Intravenous Equipment (IV) Market by End User
9.2.5.4 Spain Intravenous Equipment (IV) Market
9.2.5.4.1 Spain Intravenous Equipment (IV) Market by Product Type
9.2.5.4.2 Spain Intravenous Equipment (IV) Market by End User
9.2.5.5 United Kingdom Intravenous Equipment (IV) Market
9.2.5.5.1 United Kingdom Intravenous Equipment (IV) Market by Product Type
9.2.5.5.2 United Kingdom Intravenous Equipment (IV) Market by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Intravenous Equipment (IV) Market Overview
9.3.2 Asia-Pacific Intravenous Equipment (IV) Market Forecasts and Analysis
9.3.3 Asia-Pacific Intravenous Equipment (IV) Market Forecasts and Analysis - By Product Type
9.3.4 Asia-Pacific Intravenous Equipment (IV) Market Forecasts and Analysis - By End User
9.3.5 Asia-Pacific Intravenous Equipment (IV) Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Intravenous Equipment (IV) Market
9.3.5.1.1 Australia Intravenous Equipment (IV) Market by Product Type
9.3.5.1.2 Australia Intravenous Equipment (IV) Market by End User
9.3.5.2 China Intravenous Equipment (IV) Market
9.3.5.2.1 China Intravenous Equipment (IV) Market by Product Type
9.3.5.2.2 China Intravenous Equipment (IV) Market by End User
9.3.5.3 India Intravenous Equipment (IV) Market
9.3.5.3.1 India Intravenous Equipment (IV) Market by Product Type
9.3.5.3.2 India Intravenous Equipment (IV) Market by End User
9.3.5.4 Japan Intravenous Equipment (IV) Market
9.3.5.4.1 Japan Intravenous Equipment (IV) Market by Product Type
9.3.5.4.2 Japan Intravenous Equipment (IV) Market by End User
9.3.5.5 South Korea Intravenous Equipment (IV) Market
9.3.5.5.1 South Korea Intravenous Equipment (IV) Market by Product Type
9.3.5.5.2 South Korea Intravenous Equipment (IV) Market by End User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Intravenous Equipment (IV) Market Overview
9.4.2 Middle East and Africa Intravenous Equipment (IV) Market Forecasts and Analysis
9.4.3 Middle East and Africa Intravenous Equipment (IV) Market Forecasts and Analysis - By Product Type
9.4.4 Middle East and Africa Intravenous Equipment (IV) Market Forecasts and Analysis - By End User
9.4.5 Middle East and Africa Intravenous Equipment (IV) Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Intravenous Equipment (IV) Market
9.4.5.1.1 South Africa Intravenous Equipment (IV) Market by Product Type
9.4.5.1.2 South Africa Intravenous Equipment (IV) Market by End User
9.4.5.2 Saudi Arabia Intravenous Equipment (IV) Market
9.4.5.2.1 Saudi Arabia Intravenous Equipment (IV) Market by Product Type
9.4.5.2.2 Saudi Arabia Intravenous Equipment (IV) Market by End User
9.4.5.3 U.A.E Intravenous Equipment (IV) Market
9.4.5.3.1 U.A.E Intravenous Equipment (IV) Market by Product Type
9.4.5.3.2 U.A.E Intravenous Equipment (IV) Market by End User
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Intravenous Equipment (IV) Market Overview
9.5.2 South and Central America Intravenous Equipment (IV) Market Forecasts and Analysis
9.5.3 South and Central America Intravenous Equipment (IV) Market Forecasts and Analysis - By Product Type
9.5.4 South and Central America Intravenous Equipment (IV) Market Forecasts and Analysis - By End User
9.5.5 South and Central America Intravenous Equipment (IV) Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Intravenous Equipment (IV) Market
9.5.5.1.1 Brazil Intravenous Equipment (IV) Market by Product Type
9.5.5.1.2 Brazil Intravenous Equipment (IV) Market by End User
9.5.5.2 Argentina Intravenous Equipment (IV) Market
9.5.5.2.1 Argentina Intravenous Equipment (IV) Market by Product Type
9.5.5.2.2 Argentina Intravenous Equipment (IV) Market by End User
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL INTRAVENOUS EQUIPMENT (IV) MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Rest of the World
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. INTRAVENOUS EQUIPMENT (IV) MARKET, KEY COMPANY PROFILES
12.1. ANGIODYNAMICS, INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. B. BRAUN MELSUNGEN AG
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. BAXTER INTERNATIONAL INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BECTON, DICKINSON AND COMPANY
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. C. R. BARD, INC.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. FRESENIUS SE AND CO. KGAA
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. ICU MEDICAL, INC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. MOOG, INC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. SMITHS MEDICAL
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. TERUMO CORPORATION
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. AngioDynamics, Inc.
2. B. Braun Melsungen AG
3. Baxter International Inc.
4. Becton, Dickinson and Company
5. C. R. Bard, Inc.
6. Fresenius SE & Co. KGaA
7. ICU Medical, Inc.
8. Moog, Inc.
9. Smiths Medical
10. Terumo Corporation
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.